{"id":"https://openalex.org/W2647164","doi":null,"title":"Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.","display_name":"Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.","publication_year":1997,"publication_date":"1997-07-01","ids":{"openalex":"https://openalex.org/W2647164","mag":"2647164","pmid":"https://pubmed.ncbi.nlm.nih.gov/9262048","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1188867"},"language":"en","primary_location":{"id":"pmid:9262048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9262048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychiatry & neuroscience : JPN","raw_type":"Journal Article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1188867/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001054264","display_name":"Dennis A. Revicki","orcid":"https://orcid.org/0000-0001-6780-0019","observed_orcids":["https://orcid.org/0000-0001-6780-0019"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"D A Revicki","raw_affiliation_strings":["MEDTAP International, Bethesda, Maryland 20814, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MEDTAP International, Bethesda, Maryland 20814, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5001054264"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0412,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.80392157,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"4","first_page":"256","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7666000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7666000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.22689999639987946,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9039999842643738},{"id":"https://openalex.org/keywords/pharmacoeconomic-evaluation","display_name":"pharmacoeconomic evaluation","score":0.921999990940094},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8320000171661377},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.671999990940094},{"id":"https://openalex.org/keywords/study-design","display_name":"research design","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7429111003875732},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6574447751045227},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.608303427696228},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.546907365322113},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.5419244766235352},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4832056760787964},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4550451338291168},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.45447051525115967},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4298374056816101},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4198465645313263},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.13029900193214417},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:9262048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9262048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychiatry & neuroscience : JPN","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1188867","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1188867/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Psychiatry Neurosci","raw_type":"Text"},{"id":"mag:2647164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9262048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1188867","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1188867/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Psychiatry Neurosci","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W43076824","https://openalex.org/W122505910","https://openalex.org/W153750880","https://openalex.org/W195545715","https://openalex.org/W1519933764","https://openalex.org/W1787454655","https://openalex.org/W1842906670","https://openalex.org/W1859092351","https://openalex.org/W1974979812","https://openalex.org/W1975206633","https://openalex.org/W1992758394","https://openalex.org/W1994519701","https://openalex.org/W1999035254","https://openalex.org/W2014659268","https://openalex.org/W2015841736","https://openalex.org/W2016832763","https://openalex.org/W2018237572","https://openalex.org/W2034440069","https://openalex.org/W2040538157","https://openalex.org/W2055453916","https://openalex.org/W2059182037","https://openalex.org/W2077634393","https://openalex.org/W2079764852","https://openalex.org/W2086362482","https://openalex.org/W2101499551","https://openalex.org/W2110140555","https://openalex.org/W2116246373","https://openalex.org/W2123673366","https://openalex.org/W2135438486","https://openalex.org/W2143734450","https://openalex.org/W2149639459","https://openalex.org/W2159823337","https://openalex.org/W2412787995","https://openalex.org/W4255818521"],"related_works":["https://openalex.org/W2027825020","https://openalex.org/W3205758360","https://openalex.org/W2407571901","https://openalex.org/W2247572785","https://openalex.org/W3033524424","https://openalex.org/W2038350745","https://openalex.org/W2887184382","https://openalex.org/W1968863212","https://openalex.org/W1998569805","https://openalex.org/W2412787995"],"abstract_inverted_index":{"The":[0,36],"pharmacoeconomic":[1,39],"evaluation":[2,104],"of":[3,17,20,33,38,78,105],"psychopharmacologic":[4],"treatments":[5,49],"for":[6,108],"patients":[7],"with":[8],"schizophrenia":[9],"requires":[10],"attention":[11],"to":[12,55,74],"the":[13,21,29,52,61,76,103],"clinical":[14,87],"and":[15,31,43,58,69,86,97,100],"quality":[16],"life":[18],"effects":[19],"therapy,":[22],"as":[23,25],"well":[24],"its":[26],"impact":[27],"on":[28],"use":[30],"cost":[32],"medical":[34,64],"services.":[35],"results":[37],"studies":[40],"help":[41],"clinicians":[42],"health":[44],"care":[45],"decision":[46,88],"makers":[47],"determine":[48],"that":[50],"provide":[51],"most":[53,62],"benefit":[54],"patient":[56],"functioning":[57],"well-being":[59],"at":[60],"acceptable":[63],"cost.":[65],"Various":[66],"research":[67,95],"designs":[68,96],"methods":[70],"have":[71],"been":[72],"used":[73],"evaluate":[75],"cost-effectiveness":[77],"antipsychotic":[79,106],"drugs,":[80],"including":[81],"retrospective":[82],"studies,":[83,85],"prospective":[84],"analysis":[89],"models.":[90],"This":[91],"article":[92],"summarizes":[93],"these":[94],"their":[98],"strengths":[99],"weaknesses":[101],"in":[102],"drugs":[107],"treating":[109],"schizophrenia.":[110]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}